Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap.


Biomarkers of brain amyloidosis and neurodegeneration/synaptic dysfunction are featured in recent diagnostic criteria for Alzheimer's disease. Several gaps in our knowledge, however, need to be filled before they can be adopted clinically. The aim of this article is to describe a roadmap, developed by a multidisciplinary task force, to rationally implement… (More)
DOI: 10.1016/j.neurobiolaging.2016.02.033


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.